“Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s252. doi:10.25251/skin.7.supp.252.